Brain Cancer Trial, Recruiting (NCT05559853)

Brain Cancer Trial, Recruiting NCT05559853 Sponsor: Memorial Sloan Kettering Cancer Center Condition: Brain Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05559853 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Brain Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Healthy volunteers (for certain parts of the study):

You are 18 years old or older
You are able to understand and agree to participate in the study
You have not been diagnosed with cancer

Patients (for certain parts of the study):

You are 18 years old or older
You are able to understand and agree to participate in the study
You have at least one untreated tumor that has spread to the brain, measuring more than 1 centimeter, as confirmed by a specialist
Some patients must also have a specific type of radiation treatment (called SRS) already planned for their brain tumor(s) (confirm with trial site which part of the study this applies to)

Who may not be able to join:

You are pregnant or currently breastfeeding
You have a pre-existing health condition that increases your risk of seizures, feelings of severe anxiety in enclosed spaces (such as an MRI scanner), or a higher-than-normal risk of cardiac arrest (confirm with trial site)
You are under 18 years old

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ouri Cohen, PhD, Memorial Sloan Kettering Cancer Center

Phone: 646-608-8259

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05559853

Sponsor: Memorial Sloan Kettering Cancer Center

Phase: Not Applicable

Status: Recruiting

Condition: Brain Cancer

Trial contact: 646-608-8259

More information: https://clinicaltrials.gov/study/NCT05559853

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Healthy volunteers (for certain parts of the study):

You are 18 years old or older
You are able to understand and agree to participate in the study
You have not been diagnosed with cancer

Patients (for certain parts of the study):

You are 18 years old or older
You are able to understand and agree to participate in the study
You have at least one untreated tumor that has spread to the brain, measuring more than 1 centimeter, as confirmed by a specialist
Some patients must also have a specific type of radiation treatment (called SRS) already planned for their brain tumor(s) (confirm with trial site which part of the study this applies to)

Who may not be able to join:

You are pregnant or currently breastfeeding
You have a pre-existing health condition that increases your risk of seizures, feelings of severe anxiety in enclosed spaces (such as an MRI scanner), or a higher-than-normal risk of cardiac arrest (confirm with trial site)
You are under 18 years old

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Memorial Sloan Kettering Cancer Center

Registry

ClinicalTrials.gov

Start date

22 September 2022

Est. completion

22 September 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change of Rapid chemical exchange saturation transfer (CEST) imaging with magnetic resonance fingerprinting (MRF)/CEST-MRF parameters with and without motion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov